EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Ethnic Variation in Moyamoya Angiopathy in a Diverse New Zealand Population: A Population-Based Cohort Study

Karim M Mahawish

Neuroepidemiology · 2025

DOI: 10.1159/000548482 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Neuroepidemiology, 2025. Verfasst von Karim M Mahawish. Beteiligte Einrichtung: National Institute for Stroke and Applied Neurosciences, Auckland University of Technology, Auckland, New Zealand, tyj9598@aut.ac.nz. Hauptthemen laut MEDLINE: Moyamoya Disease. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Moyamoya angiopathy (MMA) has been reported in the ethnically diverse Auckland region of New Zealand, but the sociodemographic burden and clinical outcomes remain poorly characterised. This study aimed to determine age, sex, and prevalence of MMA stratified by ethnicity and assess clinical outcomes in adults residing in Auckland (population 1.9 million).

Methods

A retrospective review of patient records and radiology reports from 2008 to 2025 was conducted using ICD codes and keyword searches. Prevalence was estimated using national census data. Primary outcomes were functional independence (modified Rankin Score 0–2) and the composite of stroke or transient ischaemic attack. Associations were assessed using univariate and multivariate Cox regression. A pooled analysis of published cohorts was also performed for context.

Results

A total of 100 patients were identified (73% female; mean age 38.5 years, SD 17). Period prevalence was highest among Pacific peoples (11/100,000), followed by Māori (6/100,000), Asians (4/100,000), and Europeans (2/100,000). Overall prevalence increased from 0.8 to 4.5 per 100,000 between 2001 and 2025 (p ≤ 0.0001). During a median follow-up of 4.2 years, 39% experienced a cerebrovascular event, at a median of 647 days from diagnosis. Two-thirds remained functionally independent. Bilateral internal carotid artery involvement (hazard ratio [HR] 0.52, 95% confidence interval [CI]: 0.30–0.91) and recurrent cerebrovascular events (HR 0.54, 95% CI: 0.31–0.94) were associated with a reduced likelihood of functional independence, while antithrombotic use was protective (HR 2.1, 95% CI: 1.11–3.9). Functional outcomes were consistent with other international cohorts.

Conclusion

This population-based study highlights marked ethnic variation in MMA prevalence, with the highest rates in Pacific peoples, and an elevated risk of early cerebrovascular events. These findings have implications for timely diagnosis and targeted management in diverse populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Moyamoya DiseaseAdultAgedFemaleHumansMaleMiddle AgedYoung AdultCohort StudiesEthnicityNew ZealandPrevalenceRetrospective StudiesStroke

Stichwörter der Autor:innen

Ethnic disparitiesFunctional outcomeMoyamoyaNew ZealandPrevalenceRetrospective cohortStroke

Autor:innen und Institutionen

  • National Institute for Stroke and Applied Neurosciences, Auckland University of Technology, Auckland, New Zealand, tyj9598@aut.ac.nz.
  • Stroke Department, Middlemore Hospital, Auckland, New Zealand, tyj9598@aut.ac.nz.

Zitieren

APA

Mahawish, K. M. (2025). Ethnic Variation in Moyamoya Angiopathy in a Diverse New Zealand Population: A Population-Based Cohort Study. Neuroepidemiology. https://doi.org/10.1159/000548482

Vancouver

Mahawish KM. Ethnic Variation in Moyamoya Angiopathy in a Diverse New Zealand Population: A Population-Based Cohort Study. Neuroepidemiology. 2025. doi:10.1159/000548482

BibTeX
@article{Mahawish2025,
  author = {Mahawish, Karim M},
  title = {Ethnic Variation in Moyamoya Angiopathy in a Diverse New Zealand Population: A Population-Based Cohort Study},
  journal = {Neuroepidemiology},
  year = {2025},
  doi = {10.1159/000548482}
}
Kostenlos starten →